Yamaguchi N, Akazawa-Kudoh S, Sawada M, Fujimoto Y and Murayama T
Background: A Type II Diabetes mellitus showed many symptoms that brought serious for the patients. One of the problem was suppressed activity of the phagocyte ..もっと見る»
Robert J Chilton
In patients with type 2 diabetes, cardiovascular risk reduction represents an important clinical goal in light of the elevated risk of cardiovascular mortality ..もっと見る»
Kulvinder Kochar Kaur *, Gautam Nand K Allahbadia, Mandeep Singh
As we all know Diabetic Kidney Disease (DKD) represents the commonest etiology for Chronic Kidney Disease (CKD) along with end-stage renal Disease (ESRD). Earlier we have review..もっと見る»
Pooja Garg
Recombinant human erythropoietin (rhEPO) is seemingly the best restorative utilization of recombinant DNA innovation till date. It was confined in 1977 and the quality decoded i..もっと見る»
Dr. Subhash Kumar
Imeglimin is a new class of drug which has introduced recently. The molecular mechanisms are unknown, although imeglimin improves insulin sensitivity in humans. Pre-clinical stu..もっと見る»
Mark A Dykstra, Noah J Switzer, Vadim Sherman, Shahzeer Karmali and Daniel W Birch
The Roux-en-Y Gastric Bypass (RYGB) is the most successful bariatric procedure. Despite its successes, a growing number of patients who undergo RYGB present with clinically sign..もっと見る»